MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1001/jama.2018.8357

Медицинская библиотека · JAMA · 2018

Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement.

US Preventive Services Task Force, Curry Susan J, Krist Alex H, Owens Douglas K, Barry Michael J, Caughey Aaron B, Davidson Karina W, Doubeni Chyke A, Epling John W, Kemper Alex R, Kubik Martha, Landefeld C Seth, Mangione Carol M, Silverstein Michael, Simon Melissa A, Tseng Chien-Wen, Wong John B

СтатьяКлинические рекомендацииПоддержка правительства СШАПеревод пока не подготовлен

Аннотация

IMPORTANCE

Peripheral artery disease (PAD) is a manifestation of atherosclerosis in the lower limbs. It can impair walking and, in severe cases, can lead to tissue loss, infection, and amputation. In addition to morbidity directly caused by PAD, patients with PAD are at increased risk for cardiovascular disease (CVD) events, because atherosclerosis is a systemic disease that also causes coronary and cerebrovascular events.

OBJECTIVE

To update the 2013 US Preventive Services Task Force (USPSTF) recommendation on screening for PAD and CVD risk with the ankle-brachial index (ABI).

EVIDENCE REVIEW: The USPSTF reviewed the evidence on whether screening for PAD with the ABI in generally asymptomatic adults reduces morbidity or mortality from PAD or CVD. The current review expanded on the previous review to include individuals with diabetes and interventions that include supervised exercise and physical therapy intended to improve outcomes in the lower limbs.

FINDINGS: The USPSTF found few data on the accuracy of the ABI for identifying asymptomatic persons who can benefit from treatment of PAD or CVD. There are few studies addressing the benefits of treating screen-detected patients with PAD; 2 good-quality studies showed no benefit of using the ABI to manage daily aspirin therapy in unselected populations, and 2 studies showed no benefit from exercise therapy. No studies addressed the harms of screening, although the potential exists for overdiagnosis, labeling, and opportunity costs. Studies that addressed the harms of treatment showed nonsignificant results. Therefore, the USPSTF concludes that the current evidence is insufficient and that the balance of benefits and harms of screening for PAD with the ABI in asymptomatic adults cannot be determined.

CONCLUSIONS AND RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for PAD and CVD risk with the ABI in asymptomatic adults. (I statement).

Для цитирования: US Preventive Services Task Force, Curry Susan J, Krist Alex H, Owens Douglas K, Barry Michael J, Caughey Aaron B, Davidson Karina W, Doubeni Chyke A, Epling John W, Kemper Alex R, Kubik Martha, Landefeld C Seth, Mangione Carol M, Silverstein Michael, Simon Melissa A, Tseng Chien-Wen, Wong John B. Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement.. JAMA. 2018. DOI: 10.1001/jama.2018.8357.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.